The Neurodiagnostics Market is segmented by condition, with neurodegenerative diseases holding the largest share. According to the MRFR report, this segment includes Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other conditions characterized by the progressive degeneration of the nervous system. The rising global prevalence of these diseases, driven by an aging population, is a major driver of demand for neurodiagnostic tools. Early diagnosis is critical for managing these conditions, as it allows for timely intervention and treatment planning.

While neurodegenerative diseases lead, stroke and epilepsy are the fastest-growing segments. Stroke is a leading cause of disability and death worldwide, and rapid diagnosis is essential for timely treatment, such as thrombolysis or mechanical thrombectomy. Advanced neuroimaging techniques, including CT and MRI, are critical for diagnosing stroke and determining the appropriate treatment. The increasing incidence of stroke, driven by an aging population and rising rates of hypertension and diabetes, is driving demand for neurodiagnostic tools.

Epilepsy is another significant and growing segment. Epilepsy is a common neurological disorder characterized by recurrent seizures. EEG is the primary diagnostic tool for epilepsy, used to detect abnormal electrical activity in the brain. The development of long-term monitoring EEG systems and ambulatory EEG devices is improving the diagnosis and management of epilepsy. The increasing awareness of epilepsy and the availability of advanced EEG technologies are driving market growth.

Other conditions include headache disorders, sleep disorders, and traumatic brain injury (TBI). The growing awareness of these conditions and the availability of diagnostic tools are driving demand.

The growth of the neurodegenerative diseases segment is driven by the aging population and the increasing prevalence of Alzheimer's and Parkinson's diseases. The growth of the stroke and epilepsy segments is driven by the high incidence of these conditions and the critical need for rapid and accurate diagnosis. As the burden of neurological disorders continues to rise, the demand for neurodiagnostic tools is expected to increase across all condition segments.